John WILKINSON v the United Kingdom - 14659/02 [2006] ECHR 1171 (28 February 2006)

BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?
No donation is too small. If every visitor before 31 December gives just £1, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!

The European Court of Human Rights (Fourth Section), sitting on 28 February 2006 as a Chamber composed of:

Mr J. Casadevall, President,
Sir Nicolas Bratza
Mr M. Pellonpää,
Mr R. Maruste,
Mr S. Pavlovschi,
Mr J. Borrego Borrego,
Mr J. Šikuta, judges,

Having regard to the observations submitted by the respondent Government and the observations in reply submitted by the applicant,

The applicant, Mr John Wilkinson, is a United Kingdom national, who was born in 1932 and is a resident of Broadmoor Hospital in Berkshire. He was represented before the Court by Ms Scott-Moncrieff, a solicitor practising in London.

The applicant is subject to hospital and restriction orders under the Mental Health Act 1983 (“the 1983 Act”) following his conviction for rape of a minor in October 1967. He is therefore detained in a psychiatric hospital. In April 1998 the applicant suffered a mild heart attack (when he was awaiting surgery for another condition) and thereafter was diagnosed as suffering from minor coronary disease.

Throughout his period of confinement, there has been considerable debate as to whether he was mentally ill. There was a consensus that he suffered from a “psychopathic personality disorder”, a condition not classed as a mental illness. However, there was disagreement as to whether he also suffered from a mental illness.

On 11 October 1988, for example, the Mental Health Review Tribunal found that he was suffering from a mental illness. Following that decision, Dr O, the applicant’s responsible medical officer at the time, proposed treating the applicant with anti-psychotic medication. She sought a second opinion from Dr L, a second opinion appointed doctor (“SOAD”) appointed by the Mental Health Act Commission. Dr L did not give the necessary authority. He considered that there was sufficient evidence to suggest that the applicant might be suffering from a psychosis to justify treatment in the event of his agreeing to it, but not sufficient evidence to justify treatment against his wishes.

In July 1999 another responsible medical officer (“the RMO”) took over the applicant’s care. The RMO formed the view that the applicant’s pronounced paranoid beliefs and attitudes were due, not only to his personality disorder, but also to an underlying psychotic mental illness. In any event, the RMO considered anti-psychotic medication necessary to relieve the applicant of his “paranoid ideation”. These views were reflected in the RMO’s report of December 1999.

In 1999 (it is not clear precisely when), the RMO proposed the new medication to the applicant and the applicant refused it: from the outset, he made it clear that he would physically resist it. Since he was not consenting, the treatment had to be certified by a SOAD (see section 58(3)(b) of the 1983 Act below). On 31 January 2000 the RMO requested the appointment of a SOAD. Dr H (“the SOAD”), a highly experienced consultant psychiatrist, was appointed.

On 17 February 2000 the SOAD examined the applicant (it was disputed during the domestic proceedings how long this examination took: 5 minutes according to the applicant; 30-40 according to the SOAD). The SOAD issued a certificate of second opinion on that date certifying that the applicant was not capable of understanding the nature, purpose and likely effects of the proposed medication, “but that, having regard to the likelihood of the treatment alleviating or preventing a deterioration of the patient’s condition, it should be given”. The certificate authorised a plan of treatment whereby the specific drugs would be administered on a number of occasions. The SOAD also signed a Form 39 confirming that the statutory criteria had been fulfilled.

The RMO was concerned that, when faced with a threatening situation, the applicant was apt to become extremely anxious and agitated and that he had acted violently on many occasions (for example by starting fires). As a result, he and the other members of his clinical team arranged that the applicant would have no notice of the SOAD’s arrival to the hospital and that the medication would be administered immediately after the certification had been obtained.

Accordingly, on the same day that the SOAD’s certificate was signed (17 February 2000), the applicant was given anti-psychotic medication by the RMO against his will. On 2 March 2000 he was again injected with the same medication. On each occasion, the applicant physically resisted and had to be restrained by members of staff. On the first occasion, he suffered an angina attack and had to be taken to a seclusion room. The applicant claimed that he subsequently suffered significant side-effects from the treatment, including low blood pressure and chest pain.

Since a further injection was due to be administered on 16 March 2000, the applicant consulted his solicitors on 8 March 2000. The applicant sought judicial review of the decision to administer the treatment. The only relief he sought was a declaration that the proposed future treatment would be unlawful. He did not seek any relief in relation to the past treatment. On 15 March 2000 the High Court gave him leave to apply for judicial review and granted an injunction preventing further treatment pending the hearing of his substantive challenge.

His solicitors obtained a report from a consultant psychiatrist (Dr G) and the RMO and the SOAD (two of the respondents in the applicant’s proceedings) prepared witness statements.

In his first witness statement, dated 10 April 2000, the RMO said the following:

“The conclusion of my opinion is that I believe medication holds out a real prospect of giving benefit to the applicant. I wish to emphasise that what I am proposing is a trial of medication only in order to see what benefit the patient derives from it. If there is no benefit then the trial will be stopped. I believe the patient is suffering from mental illness. The essential point in my view is that whether one favours a diagnosis of mental illness or one of personality disorder a trial mediation [sic] can and should be given for the paranoia which all doctors agree is both present and considerable...

Although other psychiatrists think otherwise I think it would be unsafe to move [the applicant] to conditions of medium security without giving him a trial of medication. [The applicant] has been attempting to get the Mental Health Review Tribunal to support his moving to conditions of medium security and the Tribunal adjourned in July 1999 in order, among other things, for a report to be obtained from Dr [S]... Dr [S] reassessed him and in a report dated 25 August 1999 Dr [S] said... “I do not believe that a treatment with antipsychotic medication at the present time would be indicated”...

I wrote a letter to Dr [S] dated 3 February 2000...saying that I intended to give [the applicant] a trial of medication. Dr [S] replied in his letter of 11 February 2000 saying that he would be very happy to await the outcome. He wrote ... “I am a strong believer in a “trial of mediation”[sic] in patients such as [the applicant] who have spent many years in hospital and have been unsuccessful moving on. I can think of several patients who have successfully moved from Broadmoor to Ravenswood House where previously undiagnosed mental illness was treated with successful results. I would therefore be very interested in the outcome of any trial of antipsychotic medication”...

For the reasons above the patient’s best interests are served by trial medication. The potential benefit could be considerable enabling the patient to move on to a less secure and restrictive hospital and possible eventual return to the community. If the trial does not work the patient will be no worse off than he is at present...”

“[The applicant]’s paranoid attitudes and beliefs render him incapable upon the subject of treatment with medication...In my view he lacks capacity because of his mental illness but if we take the view expressed in Dr [G]’s report of 17.5.98...that [the applicant] only has a personality disorder and that the paranoia is due to that, then [the applicant] still, I would emphasise, does not have capacity. Whichever way we look at it, he does not believe that he shows paranoia and he therefore does not believe that he needs medication to treat it. He further believes that Broadmoor hospital and I and other doctors before me acting as agents, have sought to obstruct his discharge from the hospital. He is not able to see that medication could be of benefit to him.”

“Many patients suffer [angina] attacks from time to time and come to no harm and I have spoken with Dr [X] about this. He told me there is always a chance when [the applicant] suffers an attack of angina it will develop into a heart attack, but that chance is very small.”

The SOAD, in his first witness statement, described a 30 to 40 minute interview with the applicant. He said that he looked at the applicant’s reports, which substantiated his claim that he suffered from a personality disorder but also raised the question of his paranoid thoughts. There was no clear consensus, in his opinion, as to whether these thoughts were a part of his personality disorder or if they related to an underlying illness.

“I felt that the treatment plan proposed by the RMO was both reasonable and addressed an issue that was preventing the further rehabilitation of the patient. That the patient was experiencing paranoid ideation was apparent both from records made in his clinical notes and from his personal presentation upon examination by myself. Whether such paranoid ideation was associated with his primary diagnosis of personality disorder or was symptomatic of mental illness unconnected with that diagnosis, it was reasonable in my view to attempt to relieve [the applicant] of this symptom and would be in [the applicant]’s best interests. It is accepted clinical practice to treat persons with paranoid ideation with antipsychotic medication.”

In his report, dated 12 April 2000, Dr G said the following in relation to diagnosis:

“The prevailing view of psychiatrists who have assessed [the applicant] over the years is that he suffers from a personality disorder, and not from a psychotic mental illness.

[The RMO]’s opinion that [the applicant] has a paranoid psychotic illness does not appear to arise from evidence of new symptoms that have recently emerged, but is based on a further careful review of [the applicant]’s history and presentation. [The RMO]’s conclusion that treatment with antipsychotic medication would help [the applicant] progress after many years in Broadmoor was reached in good faith and with concern for [the applicant]’s welfare.

In my view the basis for arguing that [the applicant] suffers from a paranoid psychotic illness, or schizophrenic illness is weak and there is inadequate clinical evidence to justify such a diagnosis. There is not a good history of positive psychotic symptoms such as delusional beliefs, abnormal perceptions (e.g. hallucinations) or characteristic abnormalities of thinking and affect. There has not been a gross decline in his level of social functioning indicative of chronic psychosis. The past observations noted by [the RMO] in his tribunal report (10/12/99) of thought disorder and emotional incongruity have not been sustained and are certainly not present in [the applicant]’s current presentation. The persistent characteristics of irascibility, explosive anger, poor judgment and suspiciousness are typical of a personality disorder of a paranoid type. There should be particular caution about inferring that [the applicant]’s beliefs about Broadmoor Hospital amount to delusions. They do not have the fixed, incorrigible form of delusions. The content of some of his ideas, namely about the motivation of hospital staff, is in my view misguided and wrong, but it is psychologically understandable, given his experience, personality and the context of long term detention, and it is not wholly irrational...”

“In my view it was not appropriate under all the circumstances to administer antipsychotic medication forcibly to [the applicant]. In particular, I believe that there were significant medical risks associated with forcible medication under restraint in his case.

Antipsychotic medication is generally appropriate and beneficial in the treatment of psychotic illness but generally not in the treatment of personality disorder. The likelihood that antipsychotic medication would modify [the applicant]’s personality characteristics and help him become more relaxed and amenable was low in my opinion...

The risks and adverse effects of antipsychotic medication in [the applicant]’s case included his medical history and his psychological reactions to the treatment. He was an elderly man with ischaemic heart disease. He had consistently been opposed to taking anti-psychotic medication...

It was foreseen that antipsychotic medication would probably have to be given forcibly under restraint. [The applicant] had indicated that he would physically resist. It is known that sudden cardiac death can occasionally occur when patients are given medication under restraint. This is recognised as a special risk associated with restraint that does not apply when antipsychotic mediation is given in a normal way. The position is summarised in a Report for the Royal College of Psychiatrists ‘The Association between Antipsychotic Drugs and Sudden Death’, published in 1997 [“the College Report”].

In weighing up the reasonableness of the decision to forcibly medicate [the applicant] under restraint the two principal concerns are his adverse medical history and the equivocal evidence of medical illness...I do not think that forcible administration of antipsychotic medication under restraint was appropriate or justified.”

On 18 May 2000 the High Court refused an application, by the applicant, for an order that the RMO, the SOAD and Dr G attend the substantive judicial review hearing for cross-examination on their witness statements. On 2 October 2000, the date of the coming into force of the Human Rights Act 1998 (“the 1998 Act”), the applicant was granted permission to appeal this refusal to the Court of Appeal.

In the meantime, the SOAD withdrew his authorisation for the treatment. However, the RMO remained of the view that the applicant required anti-psychotic medication and intended to seek a further SOAD certificate to that end unless precluded from doing so by the courts.

On 18 October 2001 the Court of Appeal allowed the applicant’s appeal and held that cross-examination would be appropriate in this case.

Lord Justice Simon Brown found, referring to paragraphs 82-83 of the Herczegfalvy v. Austria judgment (of 24 September 1992, Series A no. 244), that a court must inevitably reach its own view both as to whether the applicant was indeed incapable of consenting (or refusing consent) to the treatment and, depending upon the conclusion on that issue, as to whether the proposed forcible administration of such treatment would threaten his life and so be impermissible under Article 2 of the Convention, would be degrading and so impermissible under Article 3 and would not be justifiable as both necessary and proportionate under Article 8, given the extent to which it would invade the appellant’s right to privacy.

He noted that the “super-Wednesbury test” which had been applied in judicial review cases involving Article 8 rights had been found by the European Court of Human Rights to be inadequate (Smith and Grady v. the United Kingdom, nos. 33985/96 and 33986/96, §§ 129-139, ECHR 1999 VI) and he could see no basis upon which an approach disapproved of in the context of homosexuality in the armed forces could be acceptable in the context of forcibly treating mental patients particularly as the case raised a “real question under Article 3”.

He went on to point out that if the applicant was considered to have the capacity to refuse consent to the treatment, it was difficult to suppose that he should nevertheless be forcibly subjected to it despite the RMO’s views: the impact on the applicant’s rights to autonomy and bodily inviolability was immense and its prospective benefits (not least given his extreme opposition) appeared “decidedly speculative”. Moreover, even if he was not capable of consenting, the court would need to be satisfied (in the language of the Herczegfalvy judgment) that the medical necessity had been “convincingly shown to exist ... according to the psychiatric principles generally accepted at the time.”

Accordingly, Lord Justice Simon Brown concluded that what would be required on a substantive challenge to future treatment would be a “full merits review of the propriety of the treatment proposed and, for that purpose, cross-examination of the specialists.”

Finally, he did not think that Article 14 added anything to the debate. As to Article 6 of the Convention, he stated:

“If I am correct in having concluded that the [applicant] on this challenge is entitled to have the legality of his future treatment plan determined by the court according to its own assessment of the relevant facts, then plainly the requirements of Article 6 are satisfied: the Administrative Court [on an application for judicial review] will conduct a merits review on the evidence.”

Lord Justice Brooke and Lady Justice Hale also allowed the appeal. On the question of the level of review, Lady Justice Hale had regard to Articles 3 and 8 of the Convention and found that:

“Whatever the position before the [1998 Act], the decision to impose treatment without consent upon a protesting patient is a potential invasion of his rights under Article 3 or Article 8. Super-Wednesbury is not enough. The [applicant] is entitled to a proper hearing, on the merits, of whether the statutory grounds for imposing this treatment upon him against his will are made out: i.e. whether it is treatment for the mental disorder from which he is suffering and whether it should be given to him without his consent ‘having regard to the likelihood of its alleviating or preventing a deterioration of his condition’. If they are, in other words if [the RMO] rather than [Dr G] is right, then I would hold that this treatment could be given to him.

This is not the same as saying that every patient is entitled to such a hearing in advance. Once again the analogy with arrest holds good. The RMO and SOAD are not determining his civil rights and liabilities. They are merely deciding to impose or authorise treatment in the belief that the statutory grounds for doing so exist. They do not have to go to court for advance authorisation (although as in the incapacity cases there is nothing to stop them doing so if the case is a particularly difficult or controversial one). But once a situation exists in which the treatment can be scrutinised, whether before or after the event, then that scrutiny should take place.”

Dr G prepared a supplementary report dated 27 October 2000 as to the applicant’s capacity to consent. Dr G analysed the applicant’s ability to use information and weigh it in the balance in making his decision. He considered that there were four aspects to the applicant’s opposition to the treatment, two of which were rational, one of which was partially rational and partly based on lack of insight, and the last of which was manifestly wrong and based on paranoid suspicion about the motivation of his RMO. Taking this into account Dr G reached the ‘overall judgment’ that the applicant had capacity to consent.

The RMO prepared a second witness statement, dated 23 November 2000 in response to Dr G’s original and supplementary reports. He pointed out that the conclusion of the College Report, referred to by Dr G was that:

“There are insufficient epidemiological data to prove that sudden death is more likely among people being treated with antipsychotic medication than it is among the general population. However, there are no data to prove that there is no causal connection between the use of this group of drugs and sudden death.”

He also stressed that he had given the applicant depot medication rather than a preparation which would have acted immediately. As a result, during the short period where the applicant was being given the injection and was suffering the angina attack the amount of antipsychotic drugs in his blood stream would have been negligible. There was no question of the drugs causing the angina attack. That was caused by the over-exertion.

He obtained evidence from Prof B, the convenor of the group which wrote the College Report, and from Dr D, who sat on the review panel for the said report, both of whom supported his interpretation of the report. Dr D in his letter of reply apparently stated that the risk of sudden death was very small.

“[It] is clear that [the applicant] is not able to believe treatment information which I give him because he is very suspicious about my motives, he sees me as part of a corrupt system in which individuals, including doctors, have no compunction about telling lies in order to support the system and protect themselves...

I believe that this is a considerable impairment of [the applicant]’s ability to “weigh” information and balance risks and needs in order to come to a reasonable decision, in addition to his difficulty in believing information about his mental condition and treatment needs. This is caused by his suspiciousness and anxiety which derive directly from his mental condition.

I am entirely satisfied that [the applicant] does not have capacity with respect to decisions about the treatment of his mental condition.”

The SOAD also prepared a second witness statement, dated 15 November 2000, in which he said that he had been aware of the applicant’s heart condition from the records but that he had considered that the potential benefits of the treatment outweighed the risks.

Since the Court of Appeal hearing there have been no further attempts to impose compulsory treatment and the applicant has not attempted to progress the judicial review proceedings to a substantive hearing.

Detention in a psychiatric institution pursuant to the 1983 Act does not, of itself, authorise treatment. The individual’s consent must be obtained or, if that consent is not forthcoming, Part IV of the 1983 Act applies. Section 63 provides that the treatment shall be given for the mental disorder from which the individual suffers: without compliance with this condition, the treatment is unlawful. Sections 57 and 58 of the 1983 Act then go on to provide a range of additional safeguards graded to reflect the severity of the various treatments which may be contemplated.

Section 58, the relevant section for the present case, applies to two different forms of treatment (electronic convulsive therapy and “long-term medication”). Both can only be applied on the basis of conditions set out in section 58. In the case of long-term medication, the conditions are set out in section 58 (3) and (4):

“(3) Subject to section 62 below [which makes provision for urgent treatment], a patient shall not be given any form of treatment to which this section applies unless

(a) he has consented to that treatment and either the responsible medical officer or a registered medical practitioner appointed for the purposes of this Part of this Act by the Secretary of State has certified in writing that the patient is capable of understanding its nature, purpose and likely effects and has consented to it; or

(b) a registered medical practitioner appointed as aforesaid (not being [the RMO]) has certified in writing that the patient is not capable of understanding the nature, purpose and likely effects of that treatment or has not consented to it but that, having regard to the likelihood of its alleviating or preventing a deterioration of his condition, the treatment should be given.

(4) Before giving a certificate under subsection 3(b) above the registered medical practitioner concerned shall consult two other persons who have been professionally concerned with the patient’s medical treatment, and of those persons one shall be a nurse and the other shall be neither a nurse nor a registered medical practitioner ...”

The “registered medical practitioner appointed for the purposes of this Part of this Act by the Secretary of State” referred to in section 58 (3) above is commonly referred to as an SOAD. The Mental Health Act Code of Practice (“the Code”) provides guidance as to his role. Paragraphs 16.20 -22 of the Code state that:

“The role of the SOAD is to provide an additional safeguards to protect that patient’s rights...The SOAD acts as an individual and must reach his or her own decision as to whether the proposed treatment is reasonable in the light of the general consensus of appropriate treatment for such a condition....The SOAD should seek professional opinion about the nature of the patient’s disorder and problems, the appropriateness of various forms of treatment including that proposed, and the patient’s likely response to different types of treatment. The SOAD should take into account any previous experience of comparable treatment of a similar episode or disorder. The SOAD should give due weight to the opinion, knowledge and skill of those consulted.”

a. in the case of a treatment under section 58, satisfy him or herself that the patient’s detention papers are in order;

b. interview the patient in private if possible. Others may attend if the patient and SOAD agree, or if it is thought that the doctor would be at significant risk of physical harm from the patient.

c. discuss the case with the patient’s RMO face to face, or on the telephone in exceptional circumstances;

d. consult with two other persons professionally concerned with the patient’s care as statutorily required...The SOAD should be prepared, where appropriate, to consult a wider range of persons professionally concerned with the patient’s case than those required by the Act, and, with the patient’s consent, the patient’s Nearest Relative, family, carer or advocates.”

“(1) No person shall be liable, whether on the ground of want of jurisdiction or on any other ground, to any civil or criminal proceedings to which he would have been liable apart from this section in respect of any act purporting to be done in pursuance of this Act or any regulations or rules made under this Act ... unless the act was done in bad faith or without reasonable care.

(2) No civil proceedings shall be brought against any person in any court in respect of any such act without the leave of the High Court; and no criminal proceedings shall be brought against any person in any court in respect of any such act except by or with the consent of the Director of Public Prosecutions.”

The Court of Appeal reconsidered its judgment in this case in the subsequent case of R (N) v M and others [2002] EWCA Civ 1789. The claimant in that case was also a restricted mental patient detained in hospital, who refused to consent to a treatment plan which included the administration of anti-psychotic medication by injection for her psychotic illness. The claimant obtained a report from a psychiatrist who concluded that she was unlikely to be psychotic and therefore should not be given anti-psychotic medication. An SOAD issued a certificate under section 58(3)(b) of the 1983 Act stating that the claimant was suffering from either paranoid psychosis or severe personality disorder and required regular anti-psychotic treatment. He considered that the claimant did not have the capacity to consent.

The claimant’s application for judicial review was dismissed. The High Court concluded in the light of the medical evidence that the claimant did not have capacity to consent and that the treatment was necessary in her best interests. It considered that the medical necessity for treatment had been convincingly shown in accordance with the test in the Herczegfalvy case.

The Court of Appeal dismissed the appeal. It approved the High Court’s application of the Herczegfalvy test. In addition, it stated that cross-examination should not always be necessary because, in many cases, it would be clear whether medical necessity has been convincingly shown without having to hear oral evidence. It stressed that the Court of Appeal’s decision in the present case should not be used as a charter for routine applications for cross-examination in human rights cases. It pointed out that the court’s role was “essentially one of review”.

On 3 January 2000 the Working Party of the Steering Committee on Bioethics of the Council of Europe (“the Working Party”) published a consultation paper on the protection of the human rights and dignity of people suffering from mental disorder, especially those placed as involuntary patients in a psychiatric establishment (“the White Paper”).

As to the procedures for taking a decision of involuntary placement or treatment, the White Paper said the following (at § 4.2-4.3):

“[T]he decision confirming involuntary placement or treatment should be taken by a relevant independent authority, which should base its decision on valid and reliable standards of medical expertise.

The Working Party had considered at length the notion of “relevant independent authority”...In the opinion of the Working Party, the relevant question was the independence of the body or authority which takes the decisions of placement, the independence of which could be verified by the fact that it was a different authority than the one which proposed the measure and by the fact that its decision was a sovereign decision not influenced by instructions from any source whatsoever. It was thus noted that, in some countries, the relevant authority may be a doctor authorised to take such a decision with a psychiatric establishment, for example, who should be independent in relation to the doctor who proposed the placement measure...”

“The representative of a person should be consulted but where he/she refuses consent to treatment for the person concerned, it should be possible to approach a court or court-like body with the power to respect or overturn the decision of the representative.

The Working Party was also of the opinion that a written scheme of involuntary treatment must be drawn up, if possible, in consultation with the patient, his or her representative or, where there was no representative, submitted to an independent authority for decision. The scheme should be reviewed regularly and open to modification at all times in consultation with the patient, his or her representative or an independent authority, as appropriate. Should the patient not consent to the said scheme, he or she should be able to appeal to a court or court-like body.”

This White Paper led to Recommendation Rec(2004)10 of the Committee of Ministers to member states concerning the protection of the human rights and dignity of persons with a mental disorder (“the Recommendation”), adopted by the Committee of Ministers on 22 September 2004. When adopting the decision the Permanent Representative of the United Kingdom indicated that he reserved the right of his Government not to comply with the Recommendation as a whole.

i. who have the capacity to consent and are refusing the placement or treatment concerned; or

ii. who do not have the capacity to consent and are objecting to the placement or treatment concerned.”

A person may be subject to involuntary treatment only if all the following conditions are met:

ii. the person’s condition represents a significant risk of serious harm to his or her health or to other persons;

v. where appropriate, aim to enable the use of treatment acceptable to the person as soon as possible.

2. In addition to the requirements of Article 12.1 above, the treatment plan should:

i. whenever possible be prepared in consultation with the person concerned and the person’s personal advocate or representative, if any;

ii. be reviewed at appropriate intervals and, if necessary, revised, whenever possible in consultation with the person concerned and his or her personal advocate or representative, if any.

3. Member states should ensure that involuntary treatment only takes place in an appropriate environment.

Article 20 – Procedures for taking decisions on involuntary placement and/or involuntary treatment

2. The decision to subject a person to involuntary treatment should be taken by a court or another competent body. The court or other competent body should:

ii. act in accordance with procedures provided by law based on the principle that the person concerned should be seen and consulted.

However, the law may provide that when a person is subject to involuntary placement the decision to subject that person to involuntary treatment may be taken by a doctor having the requisite competence and experience, after examination of the person concerned and taking into account his or her opinion.

3. Decisions to subject a person to involuntary placement or to involuntary treatment should be documented and state the maximum period beyond which, according to law, they should be formally reviewed. This is without prejudice to the person’s rights to reviews and appeals, in accordance with the provisions of Article 25.

4. Involuntary placement, involuntary treatment, or their extension should only take place on the basis of examination by a doctor having the requisite competence and experience, and in accordance with valid and reliable professional standards.

5. That doctor or the competent body should consult those close to the person concerned, unless the person objects, it is impractical to do so, or it is inappropriate for other reasons.

“an authority, or a person or body provided for by law which is distinct from the person or body proposing an involuntary measure, and that can make an independent decision.”

Article 25 of the Recommendation, which is also within chapter III, provides as follows:

“Article 25 – Reviews and appeals concerning the lawfulness of involuntary placement and/or involuntary treatment

1. Member states should ensure that persons subject to involuntary placement or involuntary treatment can effectively exercise the right:

ii. to have the lawfulness of the measure, or its continuing application, reviewed by a court at reasonable intervals;

iii. to be heard in person or through a personal advocate or representative at such reviews or appeals.

2. If the person, or that person’s personal advocate or representative, if any, does not request such review, the responsible authority should inform the court and ensure that the continuing lawfulness of the measure is reviewed at reasonable and regular intervals.

3. Member states should consider providing the person with a lawyer for all such proceedings before a court. Where the person cannot act for him or herself, the person should have the right to a lawyer and, according to national law, to free legal aid. The lawyer should have access to all the materials, and have the right to challenge the evidence, before the court.

4. If the person has a representative, the representative should have access to all the materials, and have the right to challenge the evidence, before the court.

5. The person concerned should have access to all the materials before the court subject to the protection of the confidentiality and safety of others according to national law. If the person has no representative, he or she should have access to assistance from a personal advocate in all procedures before a court.

6. The court should deliver its decision promptly. If it identifies any violations of the relevant national legislation it should send these to the relevant body.”

“1. Treatment for mental disorder that is not aimed at producing irreversible physical effects but may be particularly intrusive should be used only if no less intrusive means of providing appropriate care is available. Member states should ensure that the use of such treatment is:

ii. in accordance with appropriate clinical protocols reflecting international standards and safeguards;

iii. except in emergency situations as referred to in Article 12, with the person’s informed, written consent or, in the case of a person who does not have the capacity to consent, the authorisation of a court or competent body;

The applicant complained that the imposition of medical treatment against his will was a breach of the State’s negative obligations under Articles 3 and 8 of the Convention.

The applicant also argued that the authorities failed in their positive obligation under Articles 3 and 8 to provide suitable safeguards against the imposition of treatment that would violate his rights under those Articles. He specified two safeguards in particular that should have been in place: the authorities should have, of their own accord, sought approval from a court before imposing treatment; secondly, he should have been able to bring a challenge against the treatment, before it took place, in a court which would have been able to provide a suitable level of review.

In addition, he submitted that Article 6 was violated because he was not able to have a determination of his ‘civil right’ to autonomy in a court that would have provided a review on the merits.

He also complained under Article 13 of the Convention, that he did not have an effective remedy in relation to the said breaches.

Finally, he complained under Article 14 of discrimination on the basis of his status as a patient detained under the 1983 Act.

The Government pointed out that the applicant did not challenge his past treatment in the judicial review proceedings. They submitted that he could have done so – seeking, for example, a declaration and damages. There would have been no significant difference between such proceedings and other possible public law proceedings, such as declaratory proceedings in the Family Division of the High Court, or section 7 Human Rights Act proceedings. However, they considered that his reasons for not bringing judicial review proceedings in relation to past treatment were understandable and pragmatic: such proceedings would not have been worthwhile on a cost-benefit analysis.

As for private law proceedings, they argued that, in theory, the applicant could have brought a tortious claim in relation to the past treatment. However, they accepted that such a claim would have faced major factual and legal difficulties because there was no indication that either the RMO or the SOAD acted negligently or in bad faith. Thus a negligence action would not have been a realistic option. A claim for assault would also have been fraught with difficulty because of section 139(1) of the 1983 Act, which precluded any liability against the doctors in question (see above). In the circumstances, they did not submit that the applicant had failed to exhaust domestic remedies, although they did note that, in relation to past treatment, there was, in principle, an avenue which remained open.

The applicant corrected the Government’s assertion that damages would have been available in any judicial review proceedings. He pointed out that, as a result of section 31(4) of the Supreme Court Act 1981, damages were only available in judicial review proceedings where the facts give rise to a private law claim in damages in addition to the public law claim for judicial review. In addition, he asserted that no claim for negligence was made because it was not his case that the decision of the RMO and the SOAD did not accord with a reasonable body of medical opinion (the test in Bolam v Friern Hospital [1957] 2 AER 118, as modified in Bolitho v City & Hackney HA [1988] AC 232).

The Court recalls that Article 35 of the Convention only requires the exhaustion of such remedies as relate to the breaches of the Convention alleged and which at the same time can provide effective and sufficient redress. The burden of proof is on the Government claiming non-exhaustion to satisfy the Court that an effective remedy was available in theory and in practice at the relevant time namely, that the remedy was accessible, capable of providing redress in respect of the applicant’s complaints and offered reasonable prospects of success (See Akdivar and Others v. Turkey, judgment of 16 September 1996, Reports of Judgments and Decisions 1996–IV, §§ 66 and 68; and V. v. the United Kingdom [GC], no. 24888/94, § 57, ECHR-IX).

In the present case, the Government accepted that the applicant would not have had any real prospects of success in private law proceedings. The applicant made it clear that it was no part of his case that the RMO or SOAD had acted in bad faith or, further, that either had acted unreasonably (namely, not in accordance with a responsible body of medical opinion – the Bolam/Bolitho test): he thereby effectively conceded that negligence proceedings had no real prospect of success. The Court finds no reason to differ from the views of the parties and, further, finds that section 139 of the 1983 Act excluded any other civil action. It considers that private law proceedings did not offer any reasonable prospects of success and that such proceedings could not therefore be considered effective within the meaning of Article 35 § 1 of the Convention.

Although the applicant could have brought public law proceedings, he would not have been able to obtain damages in relation to past treatment. By virtue of section 31(4) of the Supreme Court Act 1981 the only remedies available in such proceedings would have been declaratory or injunctive. Given the nature of the allegations (which include inhuman and degrading treatment by the State), the Court does not consider that such remedies could be considered adequate.

In conclusion, the Court considers that the applicant’s complaints cannot be declared inadmissible for failure to exhaust domestic remedies.

The applicant submitted that the national authorities violated their negative obligation under Article 3 of the Convention by imposing medical treatment upon him against his will. He distinguished Herczegfalvy v. Austria (judgment of 24 September 1992, Series A no. 244, § 86) on the grounds that, in his case, there was compelling evidence that he had capacity to refuse treatment and/or that the treatment in question was not in his best interests. He urged the Court to conclude that the Government had failed to discharge its burden to prove the medical necessity of the treatment.

The Government argued that, at the time of the treatment in February and March 2000, there was a therapeutic need which had been convincingly demonstrated. They relied in particular on the witness statements of the RMO and the SOAD (see above).

The RMO had been responsible for the applicant’s care since July 1999. He concluded that medication held out a real prospect of giving benefit to the applicant and offered the best prospect of his progressing. His view was that it would be unsafe to move the applicant to conditions of minimum security without a trial of such medication because the applicant had attempted to do dangerous things such as arson. He considered the applicant’s heart and angina carefully. It was his view that the applicant did not have capacity to make the decision.

The SOAD interviewed the applicant, examined the clinical notes and discussed matters with a variety of those responsible for the applicant’s treatment and care. He concluded that the RMO’s treatment plan was reasonable and addressed an issue that was preventing the applicant’s further rehabilitation. He concluded that it was “accepted practice to treat persons with paranoid ideation with antipsychotic medication” and that it would be “in the patient’s best interests to do so”. He concluded that the applicant “showed little understanding of the reasons or nature of the proposed trial of medication [and] was incapable of giving or withholding his consent to such treatment”.

In response, the applicant disputed that a ‘therapeutic need’ for compulsory treatment had been ‘convincingly demonstrated’. He contended that it was not enough to demonstrate the lawfulness of the treatment to show that two doctors, acting in accordance with a reasonable body of medical opinion, considered it to be appropriate.

The applicant also complained that the State was in breach of its positive obligation to provide sufficient safeguards against the imposition of compulsory treatment in circumstances where the applicant had, or might have had, capacity to refuse treatment and did so refuse and/or where the treatment was not in his best interests. In particular, he alleged that the State had failed to provide a suitable mechanism for investigating whether the treatment would constitute a violation of Article 3 before it was imposed.

In response, the Government maintained that there was a raft of important safeguards against abuse which were more than adequate to meet Convention standards. First of all, the RMO is a doctor who acts in what he perceives to be the best interests of the patient. His professional judgment that the patient did not have capacity to make a decision and that treatment would be likely to be beneficial was the starting point. Secondly, Part IV of the 1983 Act provided for an independent second opinion to be reached in line with the judgment of the RMO before the treatment could be administered: the SOAD is appointed by the Mental Health Act Commission, an independent body and he forms his own professional judgment on the case. Thirdly, in order to form his professional opinion the SOAD is obliged to consult two persons professionally concerned with the patient’s prior treatment. Fourthly, the SOAD is subject to a Code of Practice which sets out various procedural and substantive requirements that he must fulfil in forming his second opinion. Finally, in addition to the primary safeguards, there are remedies provided by the courts. If the doctors act negligently or in bad faith, they can be sued directly. In addition, the patient can bring judicial review proceedings which, in the light of the judgment of the Court of Appeal in this case, would be a full merits review, with cross-examination if necessary. Indeed, in controversial cases, the RMO or SOAD can obtain advance authorisation from the courts.

However, they submitted that prior involvement of the courts was not required by the Convention. They pointed to the fact that the White Paper did not require decisions as to involuntary treatment to be taken by a court but only by an ‘independent authority’, which could include an independent doctor (see § 4.2-4.3 cited above). Lastly, they pointed out that, in the above-cited Herczegfalvy case, the compulsory treatment had been administered without the prior authority of a court and this had not led to a finding of a violation of Article 3 or Article 8.

The applicant responded, disputing that judicial review proceedings would have provided a ‘full merits review’. He pointed out that the scope of review in judicial review prior to 2 October 2000 (the coming into force of the 1998 Act) was governed by the Super-Wednesbury test which was not considered sufficient by the Court in Smith and Grady v. the United Kingdom (nos. 33985/96 and 33986/96, §§ 137-8, ECHR 1999 VI). Even after 2 October 2000, the courts did not go so far as to conduct a full merits review (see R (Daly) v Home Secretary [2001] 2 AC 532; R (N) v Dr M [2003] 1 WLR 562).

As to the ‘mechanisms’ which the State should have provided, he made the following points. In the first place, he should have been able to appeal against the proposed treatment to a court or court-like body before it was imposed (he relied on § 6.3-6.4 of the White Paper). Secondly, the safeguard provided by the SOAD was substantially weakened by the fact that he was only required to determine whether the proposed treatment was reasonable, not whether he agreed with it. Thirdly, there was no reason why the principles in Glass v. the United Kingdom (no. 61827/00, ECHR 2004 ...) should not apply in the present case. Lastly, the argument that the treatment should be sanctioned in advance by a court was not run in the Herczegfalvy case.

“The Court considers that the position of inferiority and powerlessness which is typical of patients confined in psychiatric hospitals calls for increased vigilance in reviewing whether the Convention has been complied with. While it is for the medical authorities to decide, on the basis of the recognised rules of medical science, on the therapeutic methods to be used, if necessary by force, to preserve the physical and mental health of patients who are entirely incapable of deciding for themselves and for whom they are therefore responsible, such patients nevertheless remain under the protection of Article 3, whose requirements permit of no derogation.

The established principles of medicine are admittedly in principle decisive in such cases; as a general rule, a measure which is a therapeutic necessity cannot be regarded as inhuman or degrading. The Court must nevertheless satisfy itself that the medical necessity has been convincingly shown to exist.”

The Court recalls that ‘medical necessity’, in this context, is not limited to life-saving treatment. It can also cover treatment, such as anti-psychotic medication, imposed as part of a therapeutic regime (see Buckley v. the United Kingdom (dec.), no. 28323/95). In addition, the decision as to what therapeutic methods are necessary is principally one for the national medical authorities: those authorities have a certain margin of appreciation in this respect since it is in the first place for them to evaluate the evidence in a particular case. The Court’s task is to review under the Convention the decisions of those authorities (see H.L. v. the United Kingdom, no. 45508/99, § 98, ECHR 2004 ...).

The Court notes that, contrary to the position in the above-cited Herczegfalvy case, the central issue raised by the applicant in this context is solely the therapeutic necessity for the treatment, as opposed to the manner in which it was administered.

In this respect, it was the opinion of the RMO, the expert who had the closest contact with the applicant at the time, that the proposed treatment was in the applicant’s best interests. In addition, the SOAD, an independent expert appointed by the Mental Health Act Commission examined the applicant, read the applicant’s medical notes, consulted with the staff concerned and he too considered that the treatment was reasonable and, in particular, that the potential benefits of treatment outweighed the risks. The applicant alleged that the SOAD’s examination lasted only five minutes. However, there was no evidence before the Court to support that assertion and the applicant himself made it clear that he did not allege that the SOAD had not taken reasonable care and indeed he conceded that he had no prospects of proving that the SOAD acted negligently. While the SOAD later withdrew his authorisation of the treatment, this does not invalidate the SOAD’s original opinion and, in any event, no evidence was presented, and the Court cannot speculate, as to his reasons for so withdrawing.

The applicant’s contention was that, even if the treatment was not negligent, it was nonetheless incorrect. The Court considers that in many areas of medicine, not least psychiatry, decisions as to treatment are complex matters of judgment. Medical experts can legitimately disagree and such disagreement is not, in itself, demonstrative of an absence of medical necessity for the relevant treatment.

In the present case, the applicant has produced evidence from Dr G, a medical expert, who ‘weighed up’ the arguments for and against the treatment and came to a different conclusion to the RMO. It is true that some of Dr G’s evidence may appear to have suggested that the RMO’s treatment was unreasonable. However, the applicant made it clear that that suggestion was not part of his case to this Court and Dr G himself accepted that the RMO’s assessment was based on a ‘careful’ review of the applicant’s history and presentation and was reached ‘in good faith and with concern for the applicant’s welfare’. Dr G also acknowledged that there was at least some possibility of the applicant’s benefiting from the treatment. Moreover, the Court notes that the RMO had significantly longer to assess the applicant than Dr G.

Furthermore, the RMO was not the first expert with care of the applicant to propose anti-psychotic treatment – Dr O, one of the applicant’s previous RMOs, had also proposed it.

Finally, the RMO’s decision to administer the anti-psychotic treatment was supported, not just by the independently appointed SOAD, but also by Dr S, who stated that he had experience of several patients, with previously undiagnosed mental illnesses, being so treated with successful results.

In conclusion, the evidence is not sufficient to show that the national authorities exceeded their margin of appreciation in diagnosing that there was a medical necessity for the treatment. As a result, this complaint must be dismissed as being manifestly ill-founded within the meaning of Article 35 § 3 of the Convention.

In Moldovan v. Romania (nos. 41138/98 and 64320/01, § 98, 12 July 2005) the Court said:

“The obligation of the High Contracting Parties under Article 1 of the Convention to secure to everyone within their jurisdiction the rights and freedoms defined in the Convention, taken together with Article 3, requires States to take measures designed to ensure that individuals within their jurisdiction are not subjected to ill-treatment, including ill-treatment administered by private individuals (see M.C. v. Bulgaria, no. 39272/98, §§ 149-50, ECHR 2004-...; A. v. the United Kingdom, judgment of 23 September 1998, Reports 1998-VI, p. 2699, § 22; Z. and Others v. the United Kingdom [GC], no. 29392/95, §§ 73-75, ECHR 2001-V, and E. and Others v. the United Kingdom, no. 33218/96, 26 November 2002).”

The Court considers that there is a particular need for States to take such measures in the context of psychiatric hospitals, where patients are typically in a position of inferiority and helplessness (see the above-cited Herczegfalvy case).

In the present case, the Court notes the safeguards in place. The medical opinion of the patient’s RMO was not sufficient to authorise the treatment: he also had to obtain a second opinion from an independently-appointed SOAD, who was obliged to consult two persons professionally concerned with the patient’s prior treatment. This SOAD was then required to weigh the benefits of the treatment against the disadvantages before deciding whether the proposed treatment was reasonable in the light of the general consensus of appropriate treatment for such a condition.

The applicant argued that there ought to have been two further safeguards: the authorities should have, of their own accord, sought approval from a court before imposing treatment; or, in the alternative, he should have been able to challenge the treatment, before it took place, in a court which would have provided a suitable level of review.

As to the first of these arguments, the Court considers that given the role fulfilled by the SOAD and the facts of the present case, Article 3 did not require a prior application to a court. The above-described Recommendation does not require medical authorities to obtain such court authorisation: even in the case of particularly intrusive involuntary treatment, the authority required by the Recommendation is that of a ‘competent body’, defined to include persons distinct from the primary decision-maker and capable of making an independent decision. While the applicant relied heavily on the above-cited case of Glass, the first applicant in that case was not detained under the 1983 Act so that its safeguards did not therefore apply to him.

As to his second argument, the Court recalls that the applicant was given two injections. It accepts that he did not have the opportunity to challenge the first injection before it took place simply because he had no notice of it. Nonetheless the Court considers that, on the facts of this case, the lack of advance warning was compatible with the Convention since such a warning was likely, on the facts of the present case, to have caused serious harm to the physical or mental health of the patient and others. Indeed, the Court notes that the Recommendation does not require States to give advance warning to patients of proposed treatment in every case.

The applicant appeared to suggest that he did not have the opportunity to challenge the second injection prior to its administration before a court that could provide a suitable level of review. However, and even assuming that Article 3 would require such a review, the Court considers that this complaint is not borne out by the facts of this case. The applicant brought proceedings in early March 2000 after the second injection and prior to the incorporation of the Convention into domestic law in October 2000. He was able to obtain an interim injunction preventing any further treatment pending the substantive hearing. That substantive hearing has not yet taken place (and neither has any further treatment) but, if it does, it would be decided on post-incorporation standards and the High Court would be required to examine whether the proposed treatment was medically necessary. There is no clear evidence that such a review would fail to measure up to the standards set by the Court in the Herczegfalvy case (see the Court of Appeal decision in this case and R (N) v M, cited above). There is equally nothing to suggest that, if the applicant had brought his challenge a week or two earlier, namely before the second injection, the situation would have been different: he would still have been able to obtain an interim injunction pending a substantive hearing; and the substantive hearing would still, in all probability, have been heard post-incorporation. Hence, on the particular facts of this case and assuming that Article 3 would require the availability of such a prior remedy, the applicant’s complaint that he had no such prior review opportunity is unsubstantiated despite the fact that the impugned treatment was proposed prior to incorporation (a contrario, the above-cited H.L. case, § 140).

In conclusion, the Court considers that it has not been shown that the State failed to fulfil its positive obligations under Article 3 of the Convention. This complaint must therefore be dismissed as manifestly ill-founded within the meaning of Article 35 § 3 of the Convention.

“In the determination of his civil rights and obligations ... everyone is entitled to a fair and public hearing...”

The applicant argued that the imposition of compulsory treatment constituted an interference with his ‘civil rights’ of self-determination or autonomy and to inviolability of the person. He submitted that he was entitled to a ‘determination’ of those rights by a Court on the merits, rather than by supervisory review. He relied, in particular, on the W. v. the United Kingdom judgment (of 8 July 1987, Series A no. 121, §§ 80-82, 87).

In so far as the applicant thereby complained that he did not have access, prior to treatment, to a court which could have provided a sufficient level of review, the Court has examined this complaint under Article 3 of the Convention above.

In so far as the applicant complained that he did not have access, after treatment, to a court that could have provided a sufficient level of review, it is recalled that the applicant did not allege that any action on the part of the RMO or the SOAD was in bad faith or unreasonable so that section 139 of the 1983 Act effectively excluded any civil action.

The Court considers this complaint to be essentially the same as those made in Ashingdane v. the United Kingdom (judgment of 28 May 1985, Series A no. 93, §§ 55-60) and James v. United Kingdom (no. 20447/92, Commission decision of 5 May 1993) and that there is nothing in the facts of the present case which would distinguish it from those cases. For the detailed reasons set out in the Ashingdane judgment and James decision, respectively, the Court considers that this complaint of the applicant discloses no appearance of a violation of Article 6 § 1 of the Convention.

It follows that this part of the application must also be rejected as being manifestly ill-founded within the meaning of Article 35 § 3 of the Convention.

The applicant further invoked this Article, which provides (in so far as relevant):

2. There shall be no interference by a public authority with the exercise of this right except such as is in accordance with the law and is necessary in a democratic society in the interests of national security ...for the protection of health ... or for the protection of the rights and freedoms of others.”

The applicant raised the same complaints under Article 8 of the Convention as under Article 3 and the Government, in their observations, made the same arguments in response.

It is not disputed, and the Court finds, that the imposition of treatment on the applicant against his will on 17 February 2000 and 8 March 2000 gave rise to an interference with his right to respect for his private life, and in particular his right to physical integrity (on the latter point, see, mutatis mutandis, X. and Y. v. the Netherlands, judgment of 26 March 1985, Series A no. 91, § 22; Pretty v. the United Kingdom, no. 2346/02, §§ 61 and 63, ECHR 2002-III and Y.F. v. Turkey, no. 24209/94, 22 July 2003, § 33). The Court also finds that this interference, pursuant to section 58(3) of the 1983 Act, was lawful and pursued the legitimate aim of protecting the applicant’s health. None of these points was disputed by the parties.

As to the necessity of the treatment, the Court refers, first of all, to its conclusions in that regard, set out above in the context of Article 3 of the Convention.

As to the capacity to consent, the Court notes that it was the opinion of the RMO that the applicant did not have such capacity. This conclusion was based on careful reasoning (see the RMO’s witness statement cited above) and supported by the independently-appointed SOAD. As with the question of therapeutic necessity, the applicant did not argue that this decision was unreasonable but, rather, asserted that it was incorrect citing the “overall judgment” to the contrary of Dr G. The Court reiterates its reasoning above concerning the differing opinions (on therapeutic necessity) of the RMO/SOAD, on the one hand, and of Dr. G, on the other. It would add that Dr G accepted that one, if not two, of the applicant’s reasons for refusing consent to treatment were based on paranoia.

In the circumstances, the Court considers that the applicant has not demonstrated that the hospital authorities were not entitled to regard him as lacking the capacity to consent to the treatment in question (see, mutatis mutandis, the above-cited Herczegfalvy judgment, at § 86). It concludes that the interference with his right to respect for his private life has not been shown to be disproportionate.

This complaint must also therefore be dismissed as manifestly ill-founded within the meaning of Article 35 § 3 of the Convention.

The Court has repeatedly held that, while the essential object of Article 8 is to protect the individual against arbitrary interference by the public authorities, it does not merely compel the State to abstain from such interference: in addition to this negative undertaking, there may be positive obligations inherent in effective respect for private or family life. These obligations may involve the adoption of measures designed to secure respect for private life (for example, Botta v. Italy, judgment of 24 February 1998, Reports 1998 I, § 33).

For the reasons set out above as regards the alleged breach of the positive obligations under Article 3, the Court considers that it cannot be said that there was a failure to provide sufficient safeguards to ensure respect for the applicant’s private life.

Accordingly, this complaint must also be rejected as being manifestly ill-founded within the meaning of Article 35 § 3 of the Convention

The applicant further complained under Article 13 that there was no effective remedy in respect of the alleged breaches of Articles 3, 6 and 8. Article 13 of the Convention provides as follows

"Everyone whose rights and freedoms as set forth in this Convention are violated shall have an effective remedy before a national authority notwithstanding that the violation has been committed by persons acting in an official capacity."

The Court recalls that Article 13 requires a domestic remedy in relation to any “arguable claim” of a violation of another Convention right: for the reasons outlined above as regards Articles 3 and 8, the Court does not consider that this application discloses any arguable claim of a violation of Articles 3 or 8 of the Convention (Boyle and Rice v United Kingdom judgment of 27 April 1988, Series A no. 131, § 52). In addition, it is not necessary to rule on the complaint under Article 13 in conjunction with Article 6 since the latter constitutes the lex specialis as regards the complaint examined thereunder.

It follows that this part of the application must be rejected as manifestly ill-founded within the meaning of Article 35 § 3 of the Convention.

"The enjoyment of the rights and freedoms set forth in this Convention shall be secured without discrimination on any ground such as sex, race, colour, language, religion, political or other opinion, national or social origin, association with a national minority, property, birth or other status."

The applicant complained that he was discriminated against on the grounds of his status as a patient in a psychiatric hospital. In particular, he submitted that there could be no justification for the fact that compulsory treatment was permitted in relation to capable individuals detained under the 1983 Act when it was not permitted in relation to other persons who were not so detained. Secondly, he submitted that he was provided with a lesser degree of legal safeguards against the imposition of unlawful treatment than the generality of patients.

The Court recalls, in the first place, that the decision of the RMO was taken on the basis of his conclusion (supported by the SOAD) that the applicant lacked capacity to consent. The Court has not accepted the applicant’s suggestion under Article 8 that the RMO’s finding was incorrect. Accordingly, there was no difference of treatment between capable individuals detained under the 1983 Act and other capable individuals, not so detained. The second complaint is undeveloped and unsubstantiated.

These complaints must, therefore, be dismissed as being manifestly ill-founded within the meaning of Article 35 § 3 of the Convention.

	[Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback]
	European Court of Human Rights
You are here: BAILII >> Databases >> European Court of Human Rights >> John WILKINSON v the United Kingdom - 14659/02 [2006] ECHR 1171 (28 February 2006) URL: http://www.bailii.org/eu/cases/ECHR/2006/1171.html Cite as: [2006] ECHR 1171